# ABVC BioPharma, Inc. (ABVC) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/ABVC
## Company Profile
- Ticker: ABVC
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States and trades on NASDAQ, placing it in the small-cap biotech category
- Tags: Oncology, CNS
## Stock Data
- Close: 0.98 USD
- Market cap: 32500552.5 USD
- Last updated: 2026-10-05
## Business Overview
### Botanical Drug and Medical Device Developer
ABVC BioPharma develops drug candidates and medical devices originating from botanical compounds and academic research. The portfolio spans central nervous system disorders, oncology, ophthalmology, and women's health.
### ABV-1505 for Adult ADHD
ABV-1505 is a botanical drug candidate being studied for adult attention-deficit hyperactivity disorder. The program is intended to offer a non-stimulant treatment approach through a standardized extract and regulated clinical-development pathway.
### Vitargus Vitreous Substitute
Vitargus is a bioengineered hydrogel being developed as a vitreous substitute for retinal surgery. The material is designed to maintain the space and optical properties of the eye after removal of the natural vitreous.
### Oncology and Additional Programs
The pipeline includes ABV-1519 for non-small cell lung cancer and other botanical candidates licensed from research institutions. Development is conducted through subsidiaries, academic collaborations, and regional clinical partners.
### BioFirst Structure
ABVC has organized several development assets through BioFirst and related entities. This structure can support separate financing, partnering, or strategic transactions around individual programs.
## Why The Stock Is Moving

As of Oct 5, 2026, ABVC closed down 2.97% at $0.9800. No new same-company headline was identified in the current news window.

## Recent News
- 2024-12-19 13:30 EST — [ABVC BioPharma Seeks to Revolutionize Mental Health Treatment With a Safe Prozac Alternative, Boasting a MADRS Score Reduction of -13.21](https://biopharmsignal.com/news/ABVC/abvc-biopharma-seeks-to-revolutionize-mental-health-treatment-with-a-safe-prozac-b7b3f3c5) — Source: ABVC BioPharma, Inc.
- 2024-12-11 11:30 EST — [ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners](https://biopharmsignal.com/news/ABVC/abvc-biopharma-secures-200-000-in-first-cash-licensing-payment-from-oncology-pro-e86c2aff) — Source: ABVC BioPharma, Inc.
- 2024-11-14 14:00 EST — [ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones](https://biopharmsignal.com/news/ABVC/abvc-biopharma-inc-reports-q3-2024-financial-results-and-operational-milestones-36204948) — Source: ABVC BioPharma, Inc.
- 2024-10-22 12:45 EST — [ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners](https://biopharmsignal.com/news/ABVC/abvc-biopharma-receives-50-000-in-incremental-licensing-fees-boosting-total-paym-f7a57177) — Source: ABVC BioPharma, Inc.
- 2024-08-15 11:30 EST — [ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements](https://biopharmsignal.com/news/ABVC/abvc-biopharma-inc-reports-strong-q2-2024-financial-results-and-strategic-achiev-5b34ed55) — Source: ABVC BioPharma, Inc.